Enjoying

HPV/Cervical Cancer

The World Health Organization (WHO) Information Centre on HPV and Cervical Cancer states the incidence of cervical cancer in Nepal is 24.2 per 100,000, making Nepal a country with one of the highest rates of cervical cancer in the world. Although Nepal currently suffers from a heavy burden of cervical cancer, there is no official WHO estimate of the distribution of HPV in Nepal.

Nepal Fertility Care Center Pema Lhaki, in conjunction with the University of Alabama at Birmingham Dr. Sadeep Shrestha, is one of the first organizations in Nepal to investigate the prevalence and social determinants of HPV infection and HPV risk behavior in Nepali women in different geographic regions. Previous studies estimate the prevalence of high-risk HPV types in other South Asian countries to be as high as 14% in the general adult population. However, data on high-risk HPV types are not yet available for the general population of Nepal and there is no national cancer registry. In an effort to learn more about the Nepali epidemic of HPV, Nepal Fertility Care Center and the University of Alabama at Birmingham are currently investigating the prevalence of HPV in Nepal’s five development regions. The information gained through this study will help clinicians to better understand the unique risk factors underlying HPV infection in Nepali women, which in turn, will help facilitate the understanding of how HPV is disseminated throughout Nepal’s 29 million citizens.


Pilot Projects*

Camp 1 – Khokana, Lalitpur district, Central Development Region


Camp 2 – Saphebagar, Accham district, Far-West Development Region


Camp 3 – Damak, Jhapa district, Far-East Development Region


Camp 4 – Inner Terai region of Dang district, Mid-Western Development Region


*All study protocols have been approved by Nepal Health Research Council.


Reports, Presentations and Publications



Collaborations and Funding Sources

University of Alabama Birmingham, Birmingham, AL

Kent State University, Kent, OH

Family Health Division, Kathmandu, Nepal

Hologic Gen-Probe, San Diego, CA